日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

YIV-818-A: a novel therapeutic agent in prostate cancer management through androgen receptor downregulation, glucocorticoid receptor inhibition, epigenetic regulation, and enhancement of apalutamide, darolutamide, and enzalutamide efficacy

YIV-818-A：一种新型前列腺癌治疗药物，其作用机制包括下调雄激素受体、抑制糖皮质激素受体、表观遗传调控以及增强阿帕鲁胺、达罗鲁胺和恩扎鲁胺的疗效。

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2023.1244655
Lam, Wing; Arammash, Mohammad; Cai, Wei; Guan, Fulan; Jiang, Zaoli; Liu, Shwu-Huey; Cheng, Peikwen; Cheng, Yung-Chi
肿瘤
表观遗传
肿瘤免疫
信号转导
前列腺癌
免疫/内分泌
发表日期：2023
文献求助 收藏

Mechanism Based Quality Control (MBQC) of Herbal Products: A Case Study YIV-906 (PHY906)

基于机理的草药产品质量控制（MBQC）：以YIV-906（PHY906）为例

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2018.01324
Lam, Wing; Ren, Yongshen; Guan, Fulan; Jiang, Zaoli; Cheng, William; Xu, Chang-Hua; Liu, Shwu-Huey; Cheng, Yung-Chi
发表日期：2018
文献求助 收藏

Safety surveillance of traditional Chinese medicine: current and future

传统中药安全监测：现状与未来

期刊:Drug Safety
影响因子:3.8
doi:10.1007/s40264-014-0250-z
Liu, Shwu-Huey; Chuang, Wu-Chang; Lam, Wing; Jiang, Zaoli; Cheng, Yung-Chi
发表日期：2015
文献求助 收藏

The number of intestinal bacteria is not critical for the enhancement of antitumor activity and reduction of intestinal toxicity of irinotecan by the Chinese herbal medicine PHY906 (KD018)

肠道细菌的数量对于中药PHY906（KD018）增强伊立替康的抗肿瘤活性和降低其肠道毒性并不重要。

期刊:BMC Complementary and Alternative Medicine
影响因子:3.4
doi:10.1186/1472-6882-14-490
Lam, Wing; Jiang, Zaoli; Guan, Fulan; Hu, Rong; Liu, Shwu-Huey; Chu, Edward; Cheng, Yung-Chi
微生物学
肿瘤
毒理研究
肿瘤免疫
发表日期：2014
文献求助 收藏

First-in-human phase II trial of the botanical formulation PHY906 with capecitabine as second-line therapy in patients with advanced pancreatic cancer

植物制剂PHY906联合卡培他滨作为二线疗法治疗晚期胰腺癌患者的首个人体II期临床试验

期刊:Cancer Chemotherapy and Pharmacology
影响因子:2.3
doi:10.1007/s00280-013-2359-7
Saif, Muhammad Wasif; Li, Jia; Lamb, Lynne; Kaley, Kristin; Elligers, Kyle; Jiang, Zaoli; Bussom, Scott; Liu, Shwu-Huey; Cheng, Yung-Chi
胰腺癌
肿瘤
肿瘤免疫
发表日期：2014
文献求助 收藏

Identification of chemicals and their metabolites from PHY906, a Chinese medicine formulation, in the plasma of a patient treated with irinotecan and PHY906 using liquid chromatography/tandem mass spectrometry (LC/MS/MS).

利用液相色谱/串联质谱法 (LC/MS/MS) 对接受伊立替康和 PHY906 治疗的患者血浆中的化学物质及其代谢物进行鉴定

期刊:Journal of Chromatography A
影响因子:4
doi:10.1016/j.chroma.2010.07.045
Zhang Wei, Saif Muhammad W, Dutschman Ginger E, Li Xin, Lam Wing, Bussom Scott, Jiang Zaoli, Ye Min, Chu Edward, Cheng Yung-Chi
代谢
发表日期：2010
文献求助 收藏